# Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve

> **NCT01879527** · PHASE2 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 78 (estimated)

## Conditions studied

- Optic; Neuritis, With Demyelination

## Interventions

- **DRUG:** Amiloride hydrochlorothiazide
- **DRUG:** Sugar pill

## Key facts

- **NCT ID:** NCT01879527
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01879527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01879527, "Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01879527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*